Rapidly Developing Medical Sector and Rising Cases of Chronic Disorders Augmenting Sales of Clinical Trial Imaging Solutions: Fact.MR Analysis

PRESS RELEASE
Published April 20, 2023

According to Fact.MR, a market research and competitive intelligence company, the global clinical trial imaging market is valued at US$ 1.15 billion in 2023 and is expected to reach US$ 2.17 billion by 2033.

A clinical trial is used to develop new medicines. It is meant to provide patients with a prospective treatment. Before new medications are released to the market, extensive clinical testing is performed to identify promising compounds, and safety checks are performed to identify any potential hazards.

Medical imaging has a significant impact on clinical trial outcomes, improving their precision and efficiency. A range of imaging modalities can be used to clarify and demonstrate the molecular activities of drugs. Clinical trial imaging is a method of clinical analysis and medical intervention that involves creating visual representations of the body’s inner organs. It contains a number of technologies that are used to see the human body in order to monitor, treat, and diagnose medical diseases. Pharma and imaging companies are constantly investing in R&D to increase their market share and supply users with cutting-edge clinical trial imaging services.

Download a Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=8259

Clinical advancement is dynamically influenced by medical imaging. The rapidly developing healthcare sector, growing cases of chronic disorders, and the rising rate of the senior population are the main factors driving target market growth.

Key Takeaways from Market Study

  • The global clinical trial imaging market is expected to increase at a CAGR of 6.5% from 2023 to 2033.
  • Sales of project & data management services are expected to rise at a CAGR of 7% during the forecast period.
  • Global demand for operational imaging services is predicted to expand at a CAGR of 6% during the next 10 years.
  • China’s market for clinical trial imaging is predicted to expand at a CAGR of 10.5% through 2033.

Key Segments of Clinical Trial Imaging Industry Research

  • By Service :
    • Project & Data Management
    • Operational Imaging Services
    • Reading & Analytical Services
    • Clinical Trial Design & Consultation Services
    • System & Technology Support Services
  • By Application :
    • Non-alcoholic Steatohepatitis
    • Oncology
    • Neurology
    • Endocrinology
    • Cardiology
    • Dermatology
    • Hematology
  • By End User :
    • Contract Research Organizations
    • Biotechnology & Pharmaceutical Companies
    • Medical Devices Manufacturers
    • Academic & Government Research Institutes
  • By Region :
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=8259

Winning Strategy

Key manufacturers of clinical trial imaging solutions are adopting new tactics to improve business operations and profitability through the creation of new products and partnerships with other market participants. The strategic actions taken by these market participants, such as new product launches, conferences, and acquisitions, help them expand and enhance their company’s product range, which in turn is increasing revenue share.

  • To submit, manage, investigate, report, and transfer medical image data that complies with universal data privacy and international requirements, Bioclinica introduced the SMART technology suite with Medical Imaging, Interactive Response Technology (IRT), and Electronic Data Capture (EDC) in June 2018.

Explore Our Safe & Secure Payment Options for Quick Buy – https://www.factmr.com/checkout/8259

Key Companies Profiled

  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • ERT Clinical
  • Icon PLC
  • Image Core Lab
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Lyscaut Medical Imaging Company
  • Medical Metrics
  • Navitas Life Sciences
  • Parexel International Corporation
  • Perspectum Diagnostics
  • Prism Clinical Imaging
  • Quotient Sciences
  • Radiant Sage LLC
  • Resonance Health
  • Worldcare Clinical, LLC

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.

Xherald

Xherald is passionate about offering extensive coverage of global business news. Dedicated to creating every participant's notification, it reaches its own reader. Daily our experts offer fresh relevant information regarding what is actually occurring in Markets as well as Business. Our headlines are actually swiftly paced and extensive. Our distributor directory connects you with brand new products or services and its market situation from the most effective companies around the planet. Xherald is driven by its 500+ contributors coming from around the world. Xherald provides local as well as global market intelligence information coverage in sectors ranging from healthcare, IOT, chemicals and 17 more sectors. Our updates are quickly paced and detailed. The news we present is actually a mix of authentic content, community contributions and curated headlines announcements. All of the updates our company supplies must pass a strict criterion of genuineness, relevance and significance to our readers.